Cellular Intelligence, an AI drug discovery company, said Moderna co-founder Bob Langer and Meta Chief AI Scientist Yann LeCun have joined its advisory board. The company focuses on using AI to advance cell biology research, with the stated goal of reshaping regenerative medicine. According to Cellular Intelligence, the two appointments are expected to speed up the use of AI in drug development, especially in work tied to understanding and intervening at the cellular level. The company also said it is building an AI-based platform designed to improve the efficiency of discovering and designing new therapies. The update was cited by Crypto Briefing and carried by Techub News.
Cellular Intelligence, an AI drug discovery company, said Moderna co-founder Bob Langer and Meta Chief AI Scientist Yann LeCun have joined its advisory board.
The company is focused on applying AI to cell biology research and says it aims to reshape regenerative medicine. Cellular Intelligence said the addition of the two experts will accelerate the use of AI in drug development, particularly in understanding and intervention at the cellular level.
The company added that it is developing an AI-based platform to make the discovery and design of new therapies more efficient.
The update was cited by Crypto Briefing.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
